Diversification was back in for investors as markets whipsawed amid tariffs and geopolitics, and even as tech stocks rally back, investors may hedge their bets.
Related Posts
FDA approves Johnson & Johnson’s nasal spray for depression as standalone treatment
Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.
Rivian meets its 2024 vehicle production target after lowering projections
Rivian on Friday said it produced 49,476 electric vehicles last year.
Waymo expands its robotaxi service again, this time to parts of Silicon Valley
With the expansion, Waymo will now take passengers around Mountain View, Los Altos, Palo Alto and parts of Sunnyvale, California.